Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Blood, Tissues, Organs
News and Events
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Our Role
Blood
Tissues and Cells
Organs
Blood and Tissues Establishments List
Inspection Process
Special Topics
News and Events
Reporting Adverse Reactions / Events
Safety Topics
HPRA Appoints New Chief Executive
News Category:
Regulatory news
Date:
14/01/2016
Ms Lorraine Nolan has been appointed as the new Chief Executive of the HPRA. Ms Nolan, who takes up office with immediate effect, previously held the position of Director of Human Products Authorisation with the HPRA where she oversaw the evaluation and authorisation of medicines and medical devices for the Irish market. Ms Nolan has extensive experience of the public health sector, the health product sector and the regulatory landscape. She will be responsible for the management of the HPRA whilst leading the organisation nationally and internationally in its ambition to protect and enhance human and animal health.
During her career to date, Ms Nolan has held a number of senior positions within the HPRA spanning the pharmaceutical assessment, products distribution and controlled drugs’ departments. Prior to joining the HPRA in 2001, she was Controlled Drugs Manager with the Department of Health and a forensic scientist with the Department of Justice, Equality and Law Reform.
Ms Nolan holds a PhD in Chemistry and a Degree in Chemistry from Trinity College, Dublin. Ms Nolan has 20 years of technical and scientific experience attained through working in regulatory (including policy development), technical, senior management, industry and public service areas within the HPRA. She has significant acumen of the public health sector with respect to medicines and health products regulation through managing frontline interaction with manufacturers, distributors, marketing authorisation holders and other stakeholders in this area.
Ms Nolan has an established profile within the national, European and international institutions for medicines, medical devices, cosmetics and controlled drugs regulation. She is a member of the European Medicines Agency (EMA) Management Board; was previously an advisor to the UN’s International Narcotic Control Board and represented Ireland at European Committees in the Cosmetics and Drug Precursor areas.
Ms Nolan succeeds Mr Pat O’Mahony who took up the position of Deputy Secretary at the Department of Health in September 2015.
« Back
Date Printed: 16/04/2024